TWST
NASDAQ
$87.45
Twist Bioscience Corp (TWST)
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company is headquartered in South San Francisco, California.
Sector:
Healthcare
Industry:
Diagnostics & Research
Buy
Target: $88.50 (+1.20%)
Market Cap
$5.76B
Revenue 5Y CAGR
+31.88%
Free Cash Flow Yield
-1.53%
Beta (5Y)
2.02
Price Chart
Valuation
Market Cap$5.76B
P/S14.08
P/B12.67
Profitability
Total Revenue (TTM)$403M
Gross Profit (TTM)$213M
EBITDA-$126M
Profit Margin-39.8%
Operating Margin-41.4%
EPS-$1.52
Financial Health
Free Cash Flow Yield-1.53%
Growth & Risk
EPS 5Y CAGR-10.29%
Revenue 5Y CAGR+31.88%
FCF 5Y CAGR-9.36%
Beta (5Y)2.02
Sharpe Ratio1.60